African Swine Fever Vaccine Candidate ASFV-G-ΔI177L Produced in the Swine Macrophage-Derived Cell Line IPKM Remains Genetically Stable and Protective against Homologous Virulent Challenge

African Swine Fever Vaccine Candidate ASFV-G-ΔI177L Produced in the Swine Macrophage-Derived Cell Line IPKM Remains Genetically Stable and Protective against Homologous Virulent Challenge

ASFV vaccine candidate ASFV-G-ΔI177L has been shown to be highly efficacious in inducing protection against challenges with the parental virus, the Georgia 2010 isolate, as well as against field strains isolated from Vietnam. ASFV-G-ΔI177L has been shown to produce protection even when used at low d...

Full description

Bibliographic Details
Main Authors: Manuel V. Borca, Ayushi Rai, Nallely Espinoza, Elizabeth Ramirez-Medina, Edward Spinard, Lauro Velazquez-Salinas, Alyssa Valladares, Ediane Silva, Leeanna Burton, Amanda Meyers, Cyril G. Gay, Douglas P. Gladue
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Viruses
Subjects:
ASFV
ASF
ASFV vaccine
ASFV-G-ΔI177L
Online Access:https://www.mdpi.com/1999-4915/15/10/2064

Internet

https://www.mdpi.com/1999-4915/15/10/2064

Similar Items